Skip to content

Buy Sun Pharma; target of Rs 1240: Motilal Oswal

Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1240 in its research report dated November 02, 2022.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish